*** Don't Miss Out! Our Full Coverage of (PLPL) Begins Today Monday 9/23. Don't Let Opportunity Pass You BUY! ***

Enter Your Email Address Below & Get Our FREE Investment Research Report on Plandai (PLPL)

*We will never sell or rent your email address to anyone. We value your privacy and hate spam as much as you.
*By submitting your email address, you consent to us sending you information on Various Publicly Traded Companies.
*There is and never will be a charge for this and or any other service offered by us. Our reports our 100% FREE

* Full Disclaimer  | Privacy Policy *

"Breast Cancer Patients Could Benefit From Plandai Phytofare(TM) Citrus Products"

ABOUT (PLPL)

In 2002, Roger Duffield, Chief Executive Officer, founded Plandaí (PLPL) Biotechnology with the original goal of delivering to the marketplace a stable, food-based emulsion to feed the masses in sub-Sahara Africa.

Today, Plandaí (PLPL) and its subsidiaries develop highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions.

Plandaí (PLPL) controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietaryk4 Phytofare™ extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutraceutical, and pharmaceutical.

The company anticipates releasing its first products to market towards the end of 1Q2014, when its state-of-the-art production facility in South Africa comes online and all of the necessary clinical trials and testing have been completed to validate the products. The first product, Phytofare™ Pheroid™ Catechin Complex, is specifically designed for nutraceutical and cosmeceutical applications and will be available as a powder, topical cream, or capsule.

(PLPL) Investor Highlights

More Than Qualified:

Plandai (PLPL) Management team has over 50 years of experience combined with a top quality scientific board.

Learn More

In The Spotlight:

The company is implementing an aggressive marketing strategy that will solidify it's mass exposure.

Learn More

Trusted Technology

Its technology and licenses are covered by multiple patents and patentpending applications, both domestic and international.

Learn More

Successfully Moving Forward:

Potential stock return, at actual price ($0.531) = over 88% in one year to over 406% in 3 years.

Learn More

Opportunity is Knocking, Will You Answer?

Subscribe Now & Receive Your FREE Investment / Research Report on
Plandai (PLPL).
This is an Immediate Buying Opportunity!

*We will never sell or rent your email address to anyone. We value your privacy and hate spam as much as you.
*By submitting your email address, you consent to us sending you information on Various Publicly Traded Companies.
*There is and never will be a charge for this and or any other service offered by us. Our reports our 100% FREE

* Full Disclaimer  | Privacy Policy *